![Tom Frohlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Frohlich
Algemeen Directeur bij
JADE BIOSCIENCES, INC.
Profiel
Tom Frohlich was the founder of Chinook Therapeutics, Inc., founded in 2019, where the title held was Chief Operating Officer from 2021 to 2023.
Mr. Frohlich is currently Chief Executive Officer & Director at Jade Biosciences, Inc. (United States) starting in 2024 and Chief Executive Officer & Director at Jade Biosciences, Inc. starting in 2025.
Former jobs include Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Entrepreneur-in-Residence at Versant Ventures Canada Ltd. Education includes an MBA from the University of Oxford in 2007 and an undergraduate degree from the University of Victoria in 1998.
Actieve functies van Tom Frohlich
| Bedrijven | Functie | Begin |
|---|---|---|
| JADE BIOSCIENCES, INC. | Algemeen Directeur | 28-04-2025 |
Eerdere bekende functies van Tom Frohlich
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Oprichter | 01-10-2023 |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Corporate Officer/Principal | 01-12-2018 |
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | 01-03-2018 |
Versant Ventures Canada Ltd.
 Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
Opleiding van Tom Frohlich
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
90
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Victoria
 University of Victoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Kies MarketScreener 
